Why Did C.R. BARD Keep Selling Problem Blood-Clot Filters?
Blood-clot filters are still being made despite their obvious and dangerous problems. A company that made an IVC filter has been found to be associated with 27 deaths and hundreds of problems. The company then replaced the device with a modified version that it knew had similar and potentially fatal flaws soon after it was put on the market.
Company records obtained by NBC News show that the medical device giant C.R. Bard was previously concerned about obvious reports of failures for its G2 series which were designed to replace the company’s Recovery filter. All this occurred within four months of being cleared to sell the G2 by the FDA.
The obvious choice of action was a recall, however, instead of recalling the G2 filter (and the virtually identical G2 Express) C.R. BARD decided to keep the filters on the shelves for five years, selling more than 160,000 units.
At least a dozen deaths and hundreds of problems are now linked to the G2 series filters, according to Bard and FDA records.